Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture

American Journal of Veterinary Research

Volumn 58, Issue 9, 1997, Pages 1027-1032

  Hay, Callum W ^a,c   Chu, Qili ^a   Budsberg, Steven C ^b   Clayton, Murray K ^a   Johnson, Kenneth A ^a,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c Tennessee Valley Vet Surg R   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANIMAL; ANIMAL DISEASE; ANTERIOR CRUCIATE LIGAMENT; ARTHROPATHY; ARTICLE; CHEMISTRY; DOG; DOG DISEASE; HINDLIMB; IMMUNOLOGY; KNEE LIGAMENT; OSTEOARTHRITIS; REFERENCE VALUE; REGRESSION ANALYSIS; RUPTURE; SYNOVIAL FLUID;

AGE FACTORS; ANIMALS; ANTERIOR CRUCIATE LIGAMENT; DOG DISEASES; DOGS; HINDLIMB; INTERLEUKIN-6; JOINT DISEASES; NITRIC OXIDE; OSTEOARTHRITIS; POSTERIOR CRUCIATE LIGAMENT; REFERENCE VALUES; REGRESSION ANALYSIS; RUPTURE; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031228062     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Johnson JA, Austin C, Breur GJ. Incidence of canine appendicular musculoskeletal disorders in 16 veterinary teaching hospitals from 1980 through 1989. Vet Comp Orthop Traumatol 1994;7:56-69.
2. Pond MJ, Nuki G. Experimentally induced osteoarthritis in the dog. Ann Rheum Dis 1973;32:387-388.
3. Ratcliffe A, Billingham ME, Fatemeh S-N, et al. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis. J Orthop Res 1992;10:350-358.
4. Woessner JF. Imbalance of proteinases and their inhibitors in osteoarthritis. In: Kuettner KE, Goldberg VM, eds. Osteoarthritic disorders. Rosemont, Ill: American Academy of Orthopaedic Surgeons, 1994;281-290.
5. Bertazzolo N, Punzi L, Stefani MP, et al. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 1994;41:90-92.
6. Remick D, DeForge LE, Sullivan JF, et al. Profile of cytokines in synovial fluid specimens from patients with arthritis. Interleukin-8 (IL-8) and IL-6 correlate with inflammatory arthritides. Immunol Invest 1992;21:321-327.
7. Caron JP, Bowker RM, Abhold RH, et al. Substance P in the synovial membrane and fluid of the equine middle carpal joint. Equine Vet J 1992;24:364-366.
8. Farrell AJ, Blake DR, Palmer RM, et al. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51:1219-1222.
9. Shinmei M, Masuda K, Kikuchi T, et al. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol 1991;18(Suppl 27):89-91.
10. Caron JP. Understanding the pathogenesis of equine osteoarthritis. Br Vet J 1992;148:369-371.
11. Pelletier J-P, Faure M-P, DiBattista JA, et al. Coordinate synthesis of stromelysin, interleukin-1 and oncogene proteins in experimental osteoarthritis: an immunohistochemical study. Am J Pathol 1993;142:95-105.
12. Westacott CI, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 1996;25: 254-272.
13. 2 release from cartilage in organ culture. Arthritis Rheum 1989;32:288-297.
14. Pettipher ER, Higgs GA, Henderson B. Interleukin-1 induces leukocyte infiltration and cartilage degradation in the synovial joint. Proc Nat Acad Sci U S A 1986;83:8749-8753.
15. Nietfeld JJ, Wilbrink M, Helle M, et al. Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis Rheum 1990; 33:1695-1701.
16. Guerne P-A, Zuraw BL, Vaughn JH, et al. Synovium as a cause of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-592.
17. Alvaro-Gracia JM, Zvaifler NJ, Firestein G. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-Gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production and granulocyle macrophage colony stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1790-1798.
18. McCarthey-Francis N, Allen JB, Mizel DE, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178:749-754.
19. Stefanovic-Racic M, Meyers K, Meschter C, et al. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthiritis Rheum 1994;37: 1062-1069.
20. Murrell GAC, Dolan MM, Jang D, et al. Nitric oxide: an important articular free radical. J Bone Joint Surg Am 1996;78:265-274.
21. Westacott CI, Whicher JT, Barnes IC, et al. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990;49:676-681.
22. Holt I, Cooper RG, Demon J, et al. Cytokine relationships and their association with disease activity in arthritis. Br J Rheumatol 1992;31:725-733.
23. Kahle P, Saal JG, Schaudt K, et al. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992;51:731-737.
24. Morris EA, McDonald BS, Webb AC, et al. Identification of interleukin-1 in equine osteoarthritic joint effusions. Am J Vet Res 1990;51:59-64.
25. Venn G, Nietfeld JJ, Duits AJ, et al. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum 1993;36:819-826.
26. Vasseur PB, Berry CR. Progression of stifle osteoarthrosis following reconstruction of the cranial cruciate ligament in 21 dogs. J Am Anim Hosp Assoc 1992;28:129-136.
27. Hay CW, Aron DN, Roberts R, et al. Evaluation of positive contrast arthrography in canine cranial cruciate ligament disease. Vet Comp Orthop Traumatol 1996;9:10-13.
28. Shi F, Kurzman ID, MacEwen EG. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs. Cancer Biother 1995;10:317-325.
29. Eskandari MK, Nguyen DT, Kunkel SL, et al. WEHI 164 Subclone 12 assay for TNF: sensitivity, specificity and reliability. Immunol Invest 1990;19:69-79.
30. Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995;272:1011-1015.
31. Snedecor GW, Cochran WG. Statistical methods. 8th ed. Ames, Iowa: Iowa State University Press, 1989;96-98, 142-144.
32. Markel MD. The power of a statistical test. What does insignificance mean? Vet Surg 1991;20:209-214.
33. Galloway RH, Lester SJ. Histopathological evaluation of canine stifle joint synovial membrane collected at the time of repair of cranial cruciate ligament rupture. J Am Anim Hosp Assoc 1995;31:289-294.
34. Arnalich F, de Migel E, Perez-Ayala C, et al. Neuropeptides and interleukin-6 in human joint inflammation. Relationship between intraarticular substance P and interleukin-6 concentrations. J Neurosci Lett 1994;170:251-254.
35. Ershler WB, Sun WH, Binkley N. The role of interleukin-6 in certain age related diseases. Drugs Aging 1994;5:358-365.
36. Bennett D, Tennart B, Lewis DG, et al. A reappraisal of anterior cruciate ligament disease in the dog. J Small Anim Pract 1988; 29:275-297.
37. Brennan FM, Gibbons DL, Cope AP, et al. TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic joint cell cultures: evidence of feedback control of TNF action. Scand J Immunol 1995;42:158-165.
38. Kammermann JR, Kincaid SA, Rumph PF, et al. Tumor necrosis factor-α (TNF-α) in canine osteoarthritis: immunolocalization of TNF-α, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cart 1996;4:23-34.
39. Todhunter PG, Kincaid SA, Todhunter RJ, et al. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. Am J Vet Res 1996;57:1080-1093.
40. Tilg H, Trechu E, Atkins MB, et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor P55. Blood 1994; 83:113-118.
41. DiGiovone FS, Nuki G, Duff GW. Tumor necrosis factor in synovial exudates. Ann Rheum Dis 1988;47:768-772.
42. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993;36:1036-1044.
43. Evans CH. Cartilage loss. In: Kuettner K, Goldberg VM, eds. Osteoarthritic disorders. Rosemont, Ill: American Academy of Orthopedic Surgeons, 1994;271-280.
44. Brinker WO, Piermattii DL, Flo GL. Handbook of small animal orthopedics and fracture treatment. Philadelphia: WB Saunders Co, 1990;285-304.
45. Niebauer GW, Wolf B, Bashey RI, et al. Antibodies to canine collagen types I and II in dogs with spontaneous cruciate ligament rupture and osteoarthritis. Arthritis Rheum 1987;30:319-327.
46. Strom H, Alexandersen S, Poulsen DM, et al. Synovial fluid proteins in degenerative joint disease in dogs. Vet Immunol Immunopathol 1989;22:187-196.
47. Griffin DW, Vasseur PB. Synovial fluid analysis in dogs with cranial cruciate ligament rupture. J Am Anim Hosp Assoc 1992;28:277-281.